Get the Stockscreener App
86.79
0.81%
0.70
Pre-market:
86.79
Vaneck Pharmaceutical Etf stock is traded at $86.79, with a volume of 137.26K.
It is up +0.81% in the last 24 hours and down -4.61% over the past month.
See More
Previous Close:
$86.09
Open:
$86.23
24h Volume:
137.26K
Relative Volume:
0.40
Market Cap:
$907.13M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.35%
1M Performance:
-4.61%
6M Performance:
-5.81%
1Y Performance:
+0.31%
1-Day Range:
$85.20
$86.88
1-Week Range:
$82.58
$86.88
52-Week Range:
$77.67
$99.51
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Name
Vaneck Pharmaceutical Etf
Sector
Industry
Phone
-
Address
-
Compare PPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
86.79 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
270.64 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
550.64 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
553.19 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
214.78 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
472.56 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Stock (PPH) Latest News
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Bought by JPMorgan Chase & Co. - Defense World
Where to Invest $10,000 Right Now - Bloomberg.com
VanEck Pharmaceutical ETF Target of Unusually High Options Trading (NASDAQ:PPH) - Defense World
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Nasdaq
ETFs in Focus Post JNJ's Q1 Earnings Beat, Dividend Hike - TradingView
Trump says pharma tariffs are coming in the “not-too-distant-future” - Seeking Alpha
PPH: Will Overcome Tariffs, But Competitor Funds Look Stronger (NASDAQ:PPH) - Seeking Alpha
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies - Benzinga
Pharma, MedTech stocks bounce back as Trump pauses most tariffs - Seeking Alpha
LPL Financial LLC Sells 35,154 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Trump says 'major tariff on pharmaceuticals' coming soon (PPH:NASDAQ) - Seeking Alpha
StockWatch: Biopharma Funds Tumble with Wall Street as Industry Spared from Worst of Tariffs—for Now - Genetic Engineering and Biotechnology News
Big Pharma higher after tariff exemption despite ongoing uncertainties - MSN
Raymond James Financial Inc. Invests $1.32 Million in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Big Pharma drops sharply ahead of Trump’s tariff announcement - MSN
Top Semiconductor Companies to Watch in 2025 - VanEck
U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs - Seeking Alpha
Commonwealth Equity Services LLC Buys 631 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by US Bancorp DE - Defense World
Assetmark Inc. Has $86,000 Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
SBI Securities Co. Ltd. Makes New Investment in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Jones Financial Companies Lllp Acquires 5,408 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - Yahoo Finance
AI-Driven Semiconductor Growth - VanEck
Atria Wealth Solutions Inc. Has $304,000 Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Novartis pulls back after report on Emasan share offering - MSN
A Better Way to Equal Weight? - VanEck
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - MSN
First Trust Nyse Arca Biotech Etf (FBT) - INDmoney
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports - Benzinga
Cencora Stock Outlook: Is Wall Street Bullish or Bearish? - TradingView
Five ETFs to invest in to hedge against policy uncertainty in 2025 - TradingView
DeepSeek’s Disruption: The Impact on Nvidia and the Semiconductor Industry - VanEck
How to profit from AI innovation in 2025 - Equities News
Is Wall Street Bullish or Bearish on AbbVie Stock? - Inkl
2025 Semiconductor Outlook: Investor Roadmap - VanEck
JPMorgan Chase & Co. Has $907,000 Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Barclays PLC Sells 3,263 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Is Investing in the WisdomTree Cloud Computing ETF (WCLD) a Smart Move - espeaks.co.uk
Gold in 2024: Central Bank Demand, Rising Prices and the Equity Disconnect - VanEck
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - MSN
Is Investing in the Invesco Semiconductors ETF (PSI) a Smart Move - espeaks.co.uk
Vaneck Pharmaceutical Etf Stock (PPH) Financials Data
There is no financial data for Vaneck Pharmaceutical Etf (PPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.20%
1.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):